Journal
ARTHRITIS RESEARCH & THERAPY
Volume 5, Issue 1, Pages 12-24Publisher
BMC
DOI: 10.1186/ar604
Keywords
bone; cartilage; collagen; metalloproteinases; tissue inhibitor of metalloproteinase
Categories
Ask authors/readers for more resources
The destruction of bone and cartilage is characteristic of the progression of musculoskeletal diseases. The present review discusses the developments made with two different classes of drugs, the bisphosphonates and matrix metalloproteinase inhibitors. Bisphosphonates have proven to be an effective and safe treatment for the prevention of bone loss, especially in osteoporotic disease, and may have a role in the treatment of arthritic diseases. The development of matrix metalloproteinase inhibitors and their role as potential therapies are also discussed, especially in the light of the disappointing human trials data so far published.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available